Elevance Renewable SciencesGlobal Leader in Natural Oil Metathesis
Rusty Pittman
VP Marketing & Business Development
July 26, 2017
Copyright 2016, Elevance Renewable Sciences, Inc. All rights reserved in this presentation as a whole and the individual slides and content thereon.
Privately held with strategic investors
Collaborations with leading chemical organizations
Global leader in natural oil metathesis
2
First to commercialize natural oil metathesis
Committed to innovation
A biotech and growth focused investor with $75 billion of capital under management
A renewable chemistry investor with a committed, long-term investment strategy
A diverse investor in resorts, natural oil production and biotechnology with a $39 billion capitalization
134 issued patents | 254 pending
Gresik, IndonesiaBiorefinery
Natural oil metathesis unlocks novel & bio-based chemicals never before accessible at scale
Elevance Proprietary Olefin Metathesis Process
Natural Oil FeedstockBiorefinery
Gresik, IndonesiaCapacity: 180,000 MT
Bio-based & Novel Chemicals
Bio-refinery Products
VERSATILE
90% Bio-based & Biodegradable
A novel solvent, intermediate, and polymer building block
UNSATURATED C10:1 METerminal olefin affords unique
reactivity
IMPROVED EFFICIENCYUnsaturation improves solubility & efficiency
Inherently Low VOC
UNSATURATED C12:1 MEUnique internal unsaturation
4
BIO SOURCEDOnly obvious source of linear olefins for many existing industrial products
LINEAR OLEFINS
C10 alpha olefinC12 ‒ C18 internal olefins
Commercial Examples
5
Unify 270
Low VOC Coalescing
Agent
C18 Polyols High
performing PU Building Blocks
Clean 1200
Non VOC Cleaning Agent
HFS
Highly Efficient & Sustainable
Fracking Additive
Soft & Smooth Personal Care
Emollients
Steposol Met-10U
Surfactant
Copyright 2016, Elevance Renewable Sciences, Inc. All rights reserved.
Typical Development Collaboration
6
Commercial Structure
• Elevance will supply proprietary chemicals
• Elevance will license relevant application IP
• Partner will manufacture new derivatives or formulated products
• Partner will market, sell, and promote new derivatives
Ideal Partner
• Leader in core markets & applications
• Open innovator & collaborator
• Application development & technical support
• Manufacturing assets
• Market access
PreliminaryEvaluation
Development
Material Transfer Agreement (MTA)• Non-exclusive• IP stand-still
Agreement: Joint Development Agreement (JDA)• Exclusive Engagement• IP ownership
Commercial
Supply Agreement• Exclusive access to
technology by segment• Volume targets & prices
Collaboration Structure Benefits
Partner Benefits
• Enables early exploration
• Jointly shares risks
• Enables products to be optimized for partner application
• Offers exclusive access for differentiated products
• Rewards early movers for increased risks
Elevance Benefits
• Ensures market validation
• Jointly shares risks
• Reduces overall development costs
• Enables access to a diverse range of markets and applications
• Accelerates development & commercialization
Partner Trade offs
• Increased development costs
• Increased risk versus utilizing commercial products
Elevance Trade Offs
• Exclusivity reduces total long term volume and revenue
• Initiation of development can be delayed 6-12 months vs doing it alone
